Prognosis of early and advanced signet ring cell gastric carcinoma compared with other histological subtypes

Background. Signet ring cell gastric carcinoma of the stomach traditionally characterized by its poor prognosis. Survival of patients with signet ring cell gastric carcinoma regardless of the stage of the disease has not been well studied.

Aim. To compare clinicopathological characteristics and survival of the patients with signet ring cell gastric carcinoma of the stomach and non-signet ring cell carcinoma depending on the stage of the disease.

Materials and methods. We performed retrospective review was undertaken of patients with gastric cancer who received surgical treatment in period from 2013–2018.

Results. At early signet ring cell cancer, the 3and 5-year survival rates was 100,0 and 89.0 %; for non-signet ring cell carcinoma 91.4 and 85.3 % (р = 0.6; Hazard Ratio (HR) 0.73; 95 % Confidence Interval (CI) 0.22–2.42) respectively. For advanced signet ring cell carcinoma, the median survival rates, 3and 5-year survival rates was 38 months, 53.0 and 38.4 %; for non-signet ring cell carcinoma 51.1 months, 59.2 and 48.0 % (р = 0.2; HR 1.2; 95 % CI 0.91–1.54).

Conclusion. Long-term results in patients with early (T1) signet ring cell cancer of the stomach did not significantly differ in comparison with other histological types of gastric cancer. Long-term results of advanced signet ring cell cancer are worse than non-signet ring cell cancer, but the differences are not statistically significant.

1. Mariette C., Carneiro F., Grabsch H.I. et al.; European Chapter of International Gastric Cancer Association. Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma. Gastric Cancer 2019;22(1):1–9. DOI: 10.1007/s10120-018-0868-0

2. Nagtegaal I.D., Odze R.D., Klimstra D. et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020;76(2):182–8. DOI: 10.1111/his.13975

3. Otsuji E., Yamaguchi T., Sawai K., Takahashi T. Characteristics of signet ring cell carcinoma of the stomach. J Surg Oncol 1998;67:216–20. DOI: 10.1002/(sici)1096-9098(199804)67:43.0.co;2-b

4. Guo Q., Wang Y., An J. et al. A prognostic model for patients with gastric signet ring cell carcinoma. Technology in cancer research & treatment. 2021;20:15330338211027912. DOI: 10.1177/15330338211027912

5. Pernot S., Voron T., Perkins G. et al. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. World J Gastroenterol 2015;21(40):11428–38. DOI: 10.3748/wjg.v21.i40.11428

6. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a hiato-clinical classification. Acta Pathol Microbiol Scand 1965;64:31–49. DOI: 10.1111/apm.1965.64.1.31

7. Nakamura K., Sugano H.,Takagi K. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gan 1968;59(3):251–8. PMID: 5726267

8. Li Y., Zhu Z., Ma F., Xue L., Tian Y. Gastric signet ring cell carcinoma: current management and future challenges. Cancer Manag Res 2020;12:7973–81. DOI: 10.2147/cmar.s268032

9. Piessen G.,Messager M.,Leteurtre E. et al. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Ann Surg 2009;250(6):878–87. DOI: 10.1097/SLA.0b013e3181b21c7b

10. Zhang C., Liu R., Zhang W.-H. et al. Difference between signet ring cell gastric cancers and non-signet ring cell gastric cancers: a systematic review and meta-analysis. Front Oncol 2021;11:618477. DOI: 10.3389/fonc.2021.618477

11. Zhao S., Lv L., Zheng K. et al. Prognosis and biological behavior of gastric signet-ring cell carcinoma better or worse: a metaanalysis. Front Oncol 2021;11:603070. DOI: 10.3389/fonc.2021.603070

12. Li C., Kim S., Lai J.F. et al. Advanced gastric carcinoma with signet ring cell histology. Oncology 2007;72(1–2):64–8. DOI: 10.1159/000111096

13. Yokota T., Kunii Y., Teshima S. et al. Signet ring cell carcinoma of the stomach: a clinicopathological comparison with the other histological types. Tohoku J Exp Med 1998;186(2):121–30. DOI: 10.1620/tjem.186.121

14. Maehara Y., Sakaguchi Y., Moriguchi S. et al. Signet ring cell carcinoma of the stomach. Cancer 1992;69(7):1645–50. DOI: 10.1002/1097-0142(19920401)69:73.0.co;2-x

15. Kunisaki C., Shimada H., Nomura M. et al. Therapeutic strategy for signet ring cell carcinoma of the stomach. Br J Surg 2004;91(10):1319–24. DOI: 10.1002/bjs.4637

16. Kim D.Y., Park Y.K., Joo J.K. et al. Clinicopathological characteristics of signet ring cell carcinoma of the stomach. ANZ J Surg 2004;74(12):1060–4. DOI: 10.1111/j.1445-1433.2004.03268.x

17. Lai Y., Xie J., Yin X.et al. Survival outcome of gastric signet ring cell carcinoma based on the optimal number of examined lymph nodes: a nomogram- and machine-learning-based approach. J Clin Med 2023;12(3):1160. DOI: 10.3390/jcm12031160

18. Taghavi S., Jayarajan S.N., Davey A., Willis A.I. Prognostic significance of signet ring gastric cancer. J Clin Oncol 2012;30(28):3493–8. DOI: 10.1200/jco.2012.42.6635

19. Kim J.P., Kim S.C., Yang H.K. Prognostic significance of signet ring cell carcinoma of the stomach. Surg Oncol 1994;3(4):221–7. DOI: 10.1016/0960-7404(94)90037-x

20. Li C., Kim S., Lai J.F. et al. Advanced gastric carcinoma with signet ring cell histology. Oncology 2007;72(1–2):64–8. DOI: 10.1159/000111096

21. Yun-He Tang, Lin-Lin Ren, Tao Mao. Update on diagnosis and treatment of early signet-ring cell gastric carcinoma: a literature review. World J Gastrointest Endosc 2023;15(4):240–7. DOI: 10.4253/wjge.v15.i4.240

22. Otsuji E., Yamaguchi T., Sawai K., Takahashi T. Characterization of signet ring cell carcinoma of the stomach. J Surg Oncol 1998;67(4):216–20. DOI: 10.1002/(sici)1096-9098(199804)67:43.0.co;2-b

23. Hyung W.J., Noh S.H., Lee J.H. et al. Early gastric carcinoma with signet ring cell histology. Cancer 2002;94(1):78–83. DOI: 10.1002/cncr.10120

24. Jin X., Wu W., Zhao J. et al. Clinical features and risk factors for lymph node metastasis in early signet ring cell gastric cancer. Front Oncol 2021;11:630675. DOI: 10.3389/fonc.2021.630675

25. Kang S.H., Kim J.S., Moon H.S. et al. Signet ring cell carcinoma of early gastric cancer, is endoscopic treatment really risky? Medicine (Baltimore) 2017;96(33):e7532. DOI: 10.1097/MD.0000000000007532

26. Ninomiya Y.,Yanagisawa A., Kato Y.,Tomimatsu H. Unrecognizable intramucosal spread of diffuse-type mucosal gastric carcinomas of less than 20 mm in size. Endoscopy 2000;32(8):604–8. DOI: 10.1055/s-2000-16506

27. Zvezda S.A., Fedorov N.M., Tamrazov R.I. et al. Morbidity and mortality of gastric signet ring cell carcinoma in the Tyumen region in 10 years period. Khirurgiya i onkologiya = Surgery and Oncology 2024;14(2):63–72. (In Russ.). DOI: 10.17650/2949-5857-2024-14-2-63-72